Journal
NEURO-ONCOLOGY
Volume 17, Issue 7, Pages 924-934Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/nov032
Keywords
chemotherapy; epilepsy; glioma; radiotherapy; review
Categories
Funding
- St. Jacobusstichting The Hague
- Foundation ZOLEON
- Foundation Chanrone
Ask authors/readers for more resources
There is growing evidence that antitumor treatment contributes to better seizure control in low-grade glioma patients. We performed a systematic review of the current literature on seizure outcome after radiotherapy and chemotherapy and evaluated the association between seizure outcome and radiological response. Twenty-four studies were available, of which 10 described seizure outcome after radiotherapy and 14 after chemotherapy. All studies demonstrated improvements in seizure outcome after antitumor treatment. Eight studies reporting on imaging response in relation to seizure outcome showed a seizure reduction in a substantial part of patients with stable disease on MRI. Seizure reduction may therefore be the only noticeable effect of antitumor treatment. Our findings demonstrate the clinical relevance of monitoring seizure outcome after radiotherapy and chemotherapy, as well as the potential role of seizure reduction as a complementary marker of tumor response in low-grade glioma patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available